
Jake Minh Vu
Examiner (ID: 8067, Phone: (571)272-8148 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1094 |
| Issued Applications | 354 |
| Pending Applications | 144 |
| Abandoned Applications | 625 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12204902
[patent_doc_number] => 20180050128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'COMPOSITION, ARTICLES AND METHODS FOR WOUND CARE'
[patent_app_type] => utility
[patent_app_number] => 15/681180
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10573
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681180
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/681180 | COMPOSITION, ARTICLES AND METHODS FOR WOUND CARE | Aug 17, 2017 | Abandoned |
Array
(
[id] => 18978832
[patent_doc_number] => 11903986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
[patent_app_type] => utility
[patent_app_number] => 15/680998
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14326
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680998
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680998 | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye | Aug 17, 2017 | Issued |
Array
(
[id] => 20226291
[patent_doc_number] => 12414930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => All-trans retinoic acid liposome formulation, and preparation and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/615281
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 8171
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615281
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615281 | All-trans retinoic acid liposome formulation, and preparation and use thereof | Aug 16, 2017 | Issued |
Array
(
[id] => 13563767
[patent_doc_number] => 20180333431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => SUSTAINED-RELEASE COMPOSITION, METHOD FOR FABRICATING, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/672280
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672280
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672280 | Sustained-release composition, method for fabricating, and use thereof | Aug 7, 2017 | Issued |
Array
(
[id] => 12136950
[patent_doc_number] => 20180015033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'METHOD AND APPARATUS FOR MINIMIZING HEAT, MOISTURE, AND SHEAR DAMAGE TO MEDICANTS AND OTHER COMPOSITIONS DURING INCORPORATION OF SAME WITH EDIBLE FILMS'
[patent_app_type] => utility
[patent_app_number] => 15/666057
[patent_app_country] => US
[patent_app_date] => 2017-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7655
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15666057
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/666057 | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films | Jul 31, 2017 | Issued |
Array
(
[id] => 13179691
[patent_doc_number] => 10105333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Pharmaceutical compositions comprising DGLA and use of same
[patent_app_type] => utility
[patent_app_number] => 15/661374
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 27940
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661374
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/661374 | Pharmaceutical compositions comprising DGLA and use of same | Jul 26, 2017 | Issued |
Array
(
[id] => 12157165
[patent_doc_number] => 20180028429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'MIXTURE OF ACTIVE INGREDIENTS FOR HAIRSTYLING COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/659638
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12169
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15659638
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/659638 | MIXTURE OF ACTIVE INGREDIENTS FOR HAIRSTYLING COMPOSITIONS | Jul 25, 2017 | Abandoned |
Array
(
[id] => 12204744
[patent_doc_number] => 20180049970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'HAIR CARE COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS'
[patent_app_type] => utility
[patent_app_number] => 15/655075
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32065
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15655075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/655075 | HAIR CARE COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | Jul 19, 2017 | Abandoned |
Array
(
[id] => 12204743
[patent_doc_number] => 20180049969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'HAIR CARE COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS'
[patent_app_type] => utility
[patent_app_number] => 15/655038
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27540
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15655038
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/655038 | HAIR CARE COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | Jul 19, 2017 | Abandoned |
Array
(
[id] => 12157450
[patent_doc_number] => 20180028715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'CARBON-BASED COMPOSITIONS USEFUL FOR OCCLUSIVE MEDICAL DEVICES AND METHODS OF MAKING AND USING THEM'
[patent_app_type] => utility
[patent_app_number] => 15/653618
[patent_app_country] => US
[patent_app_date] => 2017-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18676
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15653618
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/653618 | CARBON-BASED COMPOSITIONS USEFUL FOR OCCLUSIVE MEDICAL DEVICES AND METHODS OF MAKING AND USING THEM | Jul 18, 2017 | Abandoned |
Array
(
[id] => 14893643
[patent_doc_number] => 20190290587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA
[patent_app_type] => utility
[patent_app_number] => 16/316698
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316698 | Pulsatile drug delivery system for treating morning akinesia | Jul 10, 2017 | Issued |
Array
(
[id] => 15342771
[patent_doc_number] => 20200009277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => THIOL-MICHAEL ADDITION HYDROGEL-BASED BRACHYTHERAPY SYSTEM AND METHODS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/315188
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315188
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315188 | THIOL-MICHAEL ADDITION HYDROGEL-BASED BRACHYTHERAPY SYSTEM AND METHODS COMPRISING THE SAME | Jul 6, 2017 | Abandoned |
Array
(
[id] => 12137024
[patent_doc_number] => 20180015107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'USE OF HOMOSALATE AND OCTYL SALICYLATE TO TREAT MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/643988
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9842
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643988 | Use of homosalate and octyl salicylate to treat multiple sclerosis | Jul 6, 2017 | Issued |
Array
(
[id] => 14649311
[patent_doc_number] => 20190231784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => MODIFIED RELEASE FORMULATIONS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE
[patent_app_type] => utility
[patent_app_number] => 16/312258
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312258
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312258 | MODIFIED RELEASE FORMULATIONS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE | Jun 28, 2017 | Abandoned |
Array
(
[id] => 13714055
[patent_doc_number] => 20170367982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES
[patent_app_type] => utility
[patent_app_number] => 15/632885
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/632885 | HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES | Jun 25, 2017 | Abandoned |
Array
(
[id] => 12702070
[patent_doc_number] => 20180125856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => USE OF GLUCOCORTICOID RECEPTOR ANTAGONIST AND SOMATOSTATIN ANALOGUES TO TREAT ACTH-SECRETING TUMORS
[patent_app_type] => utility
[patent_app_number] => 15/627391
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15627391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/627391 | USE OF GLUCOCORTICOID RECEPTOR ANTAGONIST AND SOMATOSTATIN ANALOGUES TO TREAT ACTH-SECRETING TUMORS | Jun 18, 2017 | Abandoned |
Array
(
[id] => 14805951
[patent_doc_number] => 20190269585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => THICKENING AND ELONGATION OF KERATINOUS FIBERS
[patent_app_type] => utility
[patent_app_number] => 16/301928
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301928 | THICKENING AND ELONGATION OF KERATINOUS FIBERS | Jun 12, 2017 | Abandoned |
Array
(
[id] => 18259781
[patent_doc_number] => 11607467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Synthesis of nanoparticle in liquid, semi-solid media and in cells and tissues using cold plasma technology
[patent_app_type] => utility
[patent_app_number] => 15/611098
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3579
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611098
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611098 | Synthesis of nanoparticle in liquid, semi-solid media and in cells and tissues using cold plasma technology | May 31, 2017 | Issued |
Array
(
[id] => 11992340
[patent_doc_number] => 20170296495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'LIQUID DOSAGE FORMS OF SODIUM NAPROXEN'
[patent_app_type] => utility
[patent_app_number] => 15/591512
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4069
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591512
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591512 | Liquid dosage forms of sodium naproxen | May 9, 2017 | Issued |
Array
(
[id] => 12049907
[patent_doc_number] => 20170326252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'Nanoparticles for Delivery of Agents to Glioblastoma Tumors'
[patent_app_type] => utility
[patent_app_number] => 15/587407
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15384
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587407
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587407 | Nanoparticles for Delivery of Agents to Glioblastoma Tumors | May 4, 2017 | Abandoned |